UFO Moviez Q1 Ad Revenue Grows 33% YoY

Revenue: ₹1,118 million for Q1FY27 (compared to ₹1,090 million in Q1FY26 and ₹1,342 million in Q4FY26)
EBITDA: ₹189 million for Q1FY27 (compared to ₹193 million in Q1FY26 and ₹182 million in Q4FY26)
PAT: ₹56 million for Q1FY27 (compared to ₹65 million in Q1FY26 and ₹45 million in Q4FY26)
Cash Position: Consolidated cash stood at ₹1,462 million at quarter-end.
Net Cash: ₹624 million after considering outstanding debt.

Theatrical Performance: Q1FY27 witnessed encouraging theatrical momentum. The quarter commenced with the continued strong theatrical run of "Dhurandhar: The Revenge." Other notable films included "Bhooth Bangla," Malayalam film "Drishyam 3," Marathi film "Raja Shivaji," "Welcome to the Jungle," "Main Vaapas Aaunga," and "Cocktail 2."
Movie Releases: A total of 399 movies were released (including versions/languages) during the quarter, compared to 456 in Q1FY26 and 459 in Q4FY26.
Advertising Network: The company's advertising footprint stands at 3,891 screens, comprising 2,565 multiplex screens and 1,326 single screens.
Advertisement Revenue: Grew 33% year-on-year. This growth was significantly attributed to the blockbuster performance of "Dhurandhar: The Revenge," which created positive sentiment and helped secure annual advertisers. Management noted a historical revenue mix of approximately 30-40% from annual advertisers and 60-70% from tactical advertising tied to major releases.

Indian Operations Net Debtors: Reduced from ₹93.5 crore as of March 31, 2026, to ₹89.4 crore as of June 30, 2026.
Consolidated Net Debtors: Reduced from ₹152.4 crore to ₹148.1 crore.
Management highlighted that the reduction occurred despite strong advertisement revenue at the end of Q4FY26, which typically has a 120-150 day realization period.

Product sales declined significantly in the quarter.
The decline was predominantly in international product sales, which fell by approximately ₹7 crore.
This was attributed to a war situation in a region (implied to be affecting Dubai operations) that delayed imports, preventing sales recognition.
Management clarified that the orders are not lost and are expected to be executed in Q2FY27 or Q3FY27 at the latest.
Product sales in India increased marginally.

Q2FY27 Outlook: The quarter commenced on an encouraging note with the release of films such as "Alpha," "Dhamaal 4," and "Jana Nayagan."
Content Pipeline: The outlook remains positive, supported by an exciting slate of upcoming releases, including "Batwara 1947," "Toxic," "Haiwan," and "Awarapan 2."
Management expressed confidence in the theatrical business and the company's ability to capitalize on opportunities, citing a healthy content pipeline and improving industry sentiment.

A question was raised about exploring off-screen advertising (e.g., digital billboards in theater lobbies). Management acknowledged this as a potential future revenue stream but stated the current focus remains on maximizing on-screen advertising inventory.
The call was concluded with management thanking shareholders, exhibitors, advertisers, business partners, and employees.